Danny Louis Sanders, MD | |
4381 S Eason Blvd, Suite 202, Tupelo, MS 38801-6583 | |
(662) 377-6470 | |
(662) 377-6475 |
Full Name | Danny Louis Sanders |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 26 Years |
Location | 4381 S Eason Blvd, Tupelo, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760453997 | NPI | - | NPPES |
00051022 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 16481 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
North Mississippi Medical Center | Tupelo, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Mississippi Medical Center Inc | 9931010600 | 295 |
News Archive
John S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc., announced the submission of an IND application to the Food and Drug Administration to conduct a Phase I trial of its lead, anti-cancer compound, LB-100.
Mylan Inc. today announced its financial results for the three and nine months ended September 30, 2013.
Ghaith Androwis, PhD, and Steven Kirshblum, MD, received a grant from BrainQ Technologies to study a potential treatment for arm and hand dysfunction in individuals with chronic spinal cord injury.
Continued research and new policies and practices to ensure proper use and disposal of foam and plastic products that contain potentially harmful flame retardant chemicals are needed to minimize health risks from environmental exposure to humans and animals.
› Verified 1 days ago
Entity Name | North Mississippi Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972608347 PECOS PAC ID: 9931010600 Enrollment ID: O20040413000541 |
News Archive
John S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc., announced the submission of an IND application to the Food and Drug Administration to conduct a Phase I trial of its lead, anti-cancer compound, LB-100.
Mylan Inc. today announced its financial results for the three and nine months ended September 30, 2013.
Ghaith Androwis, PhD, and Steven Kirshblum, MD, received a grant from BrainQ Technologies to study a potential treatment for arm and hand dysfunction in individuals with chronic spinal cord injury.
Continued research and new policies and practices to ensure proper use and disposal of foam and plastic products that contain potentially harmful flame retardant chemicals are needed to minimize health risks from environmental exposure to humans and animals.
› Verified 1 days ago
Entity Name | Surgery Clinic Of Tupelo Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346211539 PECOS PAC ID: 0143283143 Enrollment ID: O20041110000871 |
News Archive
John S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc., announced the submission of an IND application to the Food and Drug Administration to conduct a Phase I trial of its lead, anti-cancer compound, LB-100.
Mylan Inc. today announced its financial results for the three and nine months ended September 30, 2013.
Ghaith Androwis, PhD, and Steven Kirshblum, MD, received a grant from BrainQ Technologies to study a potential treatment for arm and hand dysfunction in individuals with chronic spinal cord injury.
Continued research and new policies and practices to ensure proper use and disposal of foam and plastic products that contain potentially harmful flame retardant chemicals are needed to minimize health risks from environmental exposure to humans and animals.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Danny Louis Sanders, MD 454 E President Ave, Tupelo, MS 38801-5501 Ph: (662) 377-6470 | Danny Louis Sanders, MD 4381 S Eason Blvd, Suite 202, Tupelo, MS 38801-6583 Ph: (662) 377-6470 |
News Archive
John S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc., announced the submission of an IND application to the Food and Drug Administration to conduct a Phase I trial of its lead, anti-cancer compound, LB-100.
Mylan Inc. today announced its financial results for the three and nine months ended September 30, 2013.
Ghaith Androwis, PhD, and Steven Kirshblum, MD, received a grant from BrainQ Technologies to study a potential treatment for arm and hand dysfunction in individuals with chronic spinal cord injury.
Continued research and new policies and practices to ensure proper use and disposal of foam and plastic products that contain potentially harmful flame retardant chemicals are needed to minimize health risks from environmental exposure to humans and animals.
› Verified 1 days ago
Evan Fuller Garner, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 830 S Gloster St Fl 4, Tupelo, MS 38801 Phone: 662-377-7170 | |
Dr. Thomas Keener Billups Sr., M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1929 Allyson Dr, Tupelo, MS 38804 Phone: 662-231-2510 Fax: 662-844-3333 | |
Dr. Newt Parks Harrison Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 440 Pegram Dr, Tupelo, MS 38801 Phone: 662-844-5344 Fax: 662-844-5363 | |
Johnnie Warren Williamson, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 4381 S Eason Blvd, Suite 202, Tupelo, MS 38801 Phone: 662-377-6470 Fax: 662-377-6475 | |
Dr. Will Cauthen, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 499 Gloster Creek Vlg Ste S1, Tupelo, MS 38801 Phone: 662-377-6470 | |
Charles Gregory Pigott, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4381 S Eason Blvd, Suite 202, Tupelo, MS 38801 Phone: 662-377-6470 Fax: 662-377-6475 | |
Dr. Raymond J Orgler Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 440 Pegram Dr, Tupelo, MS 38801 Phone: 662-844-5344 Fax: 662-844-5363 |